Shareholder Votes

ROSS STORES, INC. shareholders approved Advisory Vote to Approve the Resolution on Executive Compensation at the 2026-05-20 meeting.

“In an advisory vote, the holders of the Company’s common stock voted to approve the resolution regarding executive compensation”

ROSS STORES, INC. shareholders approved Approval of the Ross Stores, Inc. 2026 Equity Incentive Plan at the 2026-05-20 meeting.

“The holders of the Company’s common stock voted to approve the 2026 Equity Incentive Plan”

ROSS STORES, INC. shareholders approved Election of Directors at the 2026-05-20 meeting.

“The holders of the Company’s common stock elected 9 nominees to serve as directors for a term of one year, expiring at the time of the Annual Meeting of Stockholders in 2027”

ILLUMINA, INC. shareholders approved Advisory approval of compensation paid to named executive officers at the 2026-05-21 meeting.

“3. On an advisory basis, approval of the compensation paid to the Company's "named executive officers" as disclosed in the Company's Proxy Statement for the Annual Meeting. This proposal was approved.”

ILLUMINA, INC. shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending January 3, 2027 at the 2026-05-21 meeting.

“2. The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending January 3, 2027. This proposal was approved.”

ILLUMINA, INC. shareholders approved Election of nine director nominees to hold office until the 2027 annual meeting at the 2026-05-21 meeting.

“1. The election of each of the following nominees to the Board of Directors to hold office for one year until the annual meeting of stockholders in the year 2027: Caroline Dorsa, Scott Gottlieb, David King, Keith Meister, Anna Richo, Philip Schiller, Susan Siegel, Jacob Thaysen and Scott Ullem. Each of the nominees has been elected to the Board of Directors.”

TETRA TECHNOLOGIES INC shareholders approved Ratification of Amendment No. 1 to the Company’s Tax Benefits Preservation Plan at the 2026-05-22 meeting.

“Item 4 – Ratification of Amendment No. 1 to the Company’s Tax Benefits Preservation Plan . The votes were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 94,361,437 7,490,191 42,525 14,168,346”

TETRA TECHNOLOGIES INC shareholders approved Ratification of the appointment of Grant Thornton LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-22 meeting.

“Item 3 – Ratification of Auditors – the stockholders approved the appointment of Grant Thornton LLP as the Company’s registered public accounting firm for the fiscal year ending December 31, 2026. The votes were as follows: Votes For Votes Against Votes Abstained 115,797,558 74,408 190,533”

TETRA TECHNOLOGIES INC shareholders approved Advisory vote to approve the compensation of named executive officers at the 2026-05-22 meeting.

“Item 2 – Advisory Vote to Approve the Compensation of Named Executive Officers – the stockholders approved, on a non-binding basis, compensation of the named executive officers as described in the Proxy Statement. The votes were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 100,758,443 1,053,739 81,971 14,168,346”

TETRA TECHNOLOGIES INC shareholders approved Election of eight members to the Board of Directors at the 2026-05-22 meeting.

“Item 1 – the election of eight members to the Company’s Board of Directors”

PRECISION BIOSCIENCES INC shareholders approved Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the other proposals. at the 2026-05-21 meeting.

“Item 6 – Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the other proposals. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 16,653,283 5,647,737 3,847 0”

PRECISION BIOSCIENCES INC shareholders approved Approval of an amendment to the Company’s Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation. at the 2026-05-21 meeting.

“Item 5 – Approval of an amendment to the Company’s Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 17,909,703 1,411,694 6,136 2,977,334”

PRECISION BIOSCIENCES INC shareholders approved Approval of the amendment and restatement of the Company’s 2019 Incentive Award Plan. at the 2026-05-21 meeting.

“Item 4 – Approval of the amendment and restatement of the Company’s 2019 Incentive Award Plan. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 11,170,635 8,145,992 10,906 2,977,334”

PRECISION BIOSCIENCES INC shareholders approved Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. at the 2026-05-21 meeting.

“Item 3 – Approval, on an advisory (non-binding) basis, of the compensation of the Company’s named executive officers. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 18,696,193 612,836 18,504 2,977,334”

PRECISION BIOSCIENCES INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. at the 2026-05-21 meeting.

“Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 22,198,597 99,879 6,391 0”

PRECISION BIOSCIENCES INC shareholders approved Election of two Class I directors to serve until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. at the 2026-05-21 meeting.

“Item 1 – Election of two Class I directors to serve until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes Melinda Brown 14,348,888 4,978,645 2,977,334 Geno Germano 14,288,270 5,039,263 2,977,334”

REPUBLIC AIRWAYS HOLDINGS INC. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-21 meeting.

“Proposal No. 3: Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026, based upon the following votes:”

REPUBLIC AIRWAYS HOLDINGS INC. shareholders approved Advisory vote to approve compensation of named executive officers at the 2026-05-21 meeting.

“Proposal No. 2: Advisory vote to approve compensation of named executive officers The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, based upon the following votes:”

REPUBLIC AIRWAYS HOLDINGS INC. shareholders approved Election of Directors at the 2026-05-21 meeting.

“Proposal No. 1 : Election of Directors The Company’s stockholders elected the following nominees as directors of the Company, each to serve until the 2027 annual meeting of stockholders, based upon the following votes:”

Transocean Ltd. shareholders approved Ratification of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2026 and reelection of Ernst & Young Ltd, Zurich, as the Company’s Auditor for a further one-year term.

“9. Proposal regarding the ratification of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2026 and reelection of Ernst & Young Ltd, Zurich, as the Company’s Auditor for a further one-year term.”

Transocean Ltd. shareholders approved Reelection of the independent proxy for a term extending until completion of the next Annual General Meeting.

“8. Proposal regarding the reelection of the independent proxy for a term extending until completion of the next Annual General Meeting.”

Transocean Ltd. shareholders approved Election of the members of the Compensation Committee, each for a term extending until completion of the next Annual General Meeting.

“7. Proposal regarding the election of the members of the Compensation Committee, each for a term extending until completion of the next Annual General Meeting.”

Transocean Ltd. shareholders approved Election of the Chair of the Board of Directors for a term extending until completion of the next Annual General Meeting.

“6. Proposal regarding the election of the Chair of the Board of Directors for a term extending until completion of the next Annual General Meeting.”

Transocean Ltd. shareholders approved Election of 11 directors, each for a term extending until completion of the next Annual General Meeting.

“5. Proposals regarding the election of 11 directors, each for a term extending until completion of the next Annual General Meeting.”

Transocean Ltd. shareholders approved Approval of Shares authorized for issuance.

“4. Proposal regarding the approval of Shares authorized for issuance.”

Transocean Ltd. shareholders approved Appropriation of the Accumulated Losses for Fiscal Year 2025.

“3. Proposal regarding the Appropriation of the Accumulated Losses for Fiscal Year 2025.”

Transocean Ltd. shareholders approved Discharge of the Members of the Board of Directors and the Executive Management Team from liability for activities during Fiscal Year 2025.

“2. Proposal regarding the discharge of the Members of the Board of Directors and the Executive Management Team from liability for activities during Fiscal Year 2025.”

Transocean Ltd. shareholders approved Advisory vote to approve the Company’s Swiss Statutory Report on Non-Financial Matters Report for Fiscal Year 2025.

“1. (C) Proposal regarding the advisory vote to approve the Company’s Swiss Statutory Report on Non-Financial Matters Report for Fiscal Year 2025.”

Transocean Ltd. shareholders approved Advisory vote to approve the Company’s Swiss Statutory Compensation Report for Fiscal Year 2025.

“1. (B) Proposal regarding the advisory vote to approve the Company’s Swiss Statutory Compensation Report for Fiscal Year 2025.”

Transocean Ltd. shareholders approved Approval of the 2025 Annual Report, including the Audited Consolidated Financial Statements and Audited Statutory Financial Statements for Fiscal Year 2025.

“1. (A) Proposal regarding the approval of the 2025 Annual Report, including the Audited Consolidated Financial Statements of the Company. for Fiscal Year 2025 and the Audited Statutory Financial Statements of the Company for Fiscal Year 2025.”

Ultra Clean Holdings, Inc. shareholders approved Approval of the amendment and restatement of the Company’s employee stock purchase plan to increase the number of shares available for issuance under the ESPP by an additional 450,000 shares at the 2026-05-22 meeting.

“Proposal 5 Approval of the amendment and restatement of the Company’s employee stock purchase plan (the “ESPP”) to increase the number of shares available for issuance under the ESPP by an additional 450,000 shares. For Against Abstain Broker Non-Votes 35,885,605 23,182 108,830 4,399,277”

Ultra Clean Holdings, Inc. shareholders approved Approval of the amendment and restatement of the Company’s stock incentive plan to increase the number of shares available for issuance under the Plan by an additional 3,500,000 shares at the 2026-05-22 meeting.

“Proposal 4 Approval of the amendment and restatement of the Company’s stock incentive plan (the “Plan”) to increase the number of shares available for issuance under the Plan by an additional 3,500,000 shares. For Against Abstain Broker Non-Votes 34,373,240 1,526,066 118,311 4,399,277”

Ultra Clean Holdings, Inc. shareholders approved Approval, by non-binding advisory vote, of the compensation paid by the Company to its Named Executive Officers at the 2026-05-22 meeting.

“Proposal 3 Approval, by non-binding advisory vote, of the compensation paid by the Company to its Named Executive Officers. For Against Abstain Broker Non-Votes 35,100,113 773,047 144,457 4,399,277”

Ultra Clean Holdings, Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP to serve as the Company’s independent registered public accounting firm for fiscal 2026 at the 2026-05-22 meeting.

“Proposal 2 Ratification of the appointment of PricewaterhouseCoopers LLP to serve as the Company’s independent registered public accounting firm for fiscal 2026. For Against Abstain 40,130,181 183,200 103,513”

Ultra Clean Holdings, Inc. shareholders approved Election of directors for a one-year term at the 2026-05-22 meeting.

“Proposal 1 Election of directors for a one-year term. Director For Against Abstain Broker Non-Votes Thomas T. Edman 35,583,689 420,800 13,128 4,399,277 James Xiao 35,497,518 506,734 13,365 4,399,277 Clarence L. Granger 35,515,152 489,995 12,470 4,399,277 David T. ibnAle 33,590,773 2,413,324 13,520 4,399,277 Emily M. Liggett 33,594,708 2,411,196 11,713 4,399,277 Ernest E. Maddock 35,812,702 193,074 11,841 4,399,277 Jacqueline A. Seto 35,604,277 401,727 11,613 4,399,277 Joanne Solomon 35,883,333 123,624 10,660 4,399,277”

APA Corp shareholders approved Approval of Amendment to the 2016 Omnibus Compensation Plan.

“Proposal 4 — Approval of Amendment to the 2016 Omnibus Compensation Plan . The Amendment as disclosed in the Proxy Statement was approved by the majority of shares voted, excluding abstentions and broker non-votes. For Against Abstentions Broker Non-Votes 266,499,823 10,989,332 642,903 34,089,789”

APA Corp shareholders approved Non-Binding Advisory Vote on Executive Compensation.

“Proposal 3 — Non-Binding Advisory Vote on Executive Compensation. In a non-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the Proxy Statement (commonly known as “say on pay”), the compensation of the Company’s named executive officers was approved by the majority of shares voted, excluding abstentions and broker non-votes. For Against Abstentions Broker Non-Votes 238,710,645 38,762,516 658,897 34,089,789”

APA Corp shareholders approved Ratification of Appointment of Independent Auditor.

“Proposal 2 — Ratification of Appointment of Independent Auditor. The appointment of Ernst & Young LLP as the Company’s independent auditor for fiscal year 2026 was ratified by the majority of shares voted, excluding abstentions and broker non-votes. For Against Abstentions Broker Non-Votes 307,082,415 4,653,628 485,804 0”

APA Corp shareholders approved Election of Directors.

“Proposal 1 — Election of Directors. The following nominees for directors were elected to serve one-year terms expiring at the 2027 annual meeting of shareholders by the majority of shares voted, excluding abstentions and broker non-votes. Nominee For Against Abstentions Broker Non-Votes Annell R. Bay 269,919,835 7,802,862 409,361 34,089,789 John J. Christmann IV 275,118,068 2,608,513 405,477 34,089,789 Juliet S. Ellis 271,823,321 5,685,806 622,931 34,089,789 Kenneth M. Fisher 276,348,675 1,366,864 416,519 34,089,789 Charles W. Hooper 274,795,166 2,918,985 417,906 34,089,789 Chansoo Joung 274,003,759 3,708,825 419,474 34,089,789 H. Lamar McKay 276,435,125 1,286,135 410,798 34,089,789 Peter A. Ragauss 274,587,738 3,118,147 426,173 34,089,789 David L. Stover 275,026,460 2,699,058 406,540 34,089,789 Anya Weaving 275,421,441 2,081,920 628,696 34,089,789”

AEMETIS, INC shareholders approved Ratification of KPMG LLP as independent registered public accounting firm at the 2026-05-20 meeting.

“Proposal 2: Ratification of Auditor For Against Abstain Broker Non-Votes 37,777,860 85,378 376,596 0”

AEMETIS, INC shareholders approved Election of Director Nominee at the 2026-05-20 meeting.

“Proposal 1: Election of Director Nominee For Withhold Broker Non-Votes Lydia I. Beebe 18,110,640 627,847 19,501,347”

Vera Therapeutics, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-05-21 meeting.

“Proposal 3 – Advisory Vote on Executive Compensation. The Company’s stockholders approved, on an advisory basis, the compensation awarded to the Company’s named executive officers, as disclosed in the Proxy Statement. The final voting results are as follows: For Against Abstain Broker Non-Votes 56,585,568 2,433,537 84,276 2,863,469”

Vera Therapeutics, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

“Proposal 2 – Ratification of the Appointment of Independent Registered Public Accounting Firm. The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. The final voting results are as follows: For Against Abstain 61,834,842 44,710 87,298”

Vera Therapeutics, Inc. shareholders approved Election of Directors at the 2026-05-21 meeting.

“Proposal 1– Election of Directors. The Company’s stockholders elected the three persons listed below as Class II Directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or, if sooner, such director’s death, resignation or removal. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Michael M. Morrisey, Ph.D. 45,288,710 13,814,671 2,863,469 Patrick G. Enright 54,697,296 4,406,085 2,863,469 James R. Meyers 58,946,269 157,112 2,863,469”

TaskUs, Inc. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

“For Against Abstain Broker Non-Votes 580,193,071 143,134 18,233 0”

TaskUs, Inc. shareholders approved Election of Class II Directors at the 2026-05-21 meeting.

“For Withheld Broker Non-Votes Jaspar Weir 574,749,347 942,204 4,662,887 Michelle Gonzalez 575,621,993 69,558 4,662,887 Amit Dalmia 574,737,643 953,908 4,662,887”

Viking Therapeutics, Inc. shareholders approved Approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement at the 2026-05-19 meeting.

“Proposal No. 3. To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement: Votes For Votes Against Abstentions Broker Non-Votes 30,045,938 12,763,135 401,396 36,879,063”

Viking Therapeutics, Inc. shareholders approved Ratify the selection of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-19 meeting.

“Proposal No. 2. To ratify the selection of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2026: Votes For Votes Against Abstentions 78,368,957 1,241,969 478,606”

Viking Therapeutics, Inc. shareholders approved Elect J. Matthew Singleton and S. Kathryn Rouan, Ph.D. as Class II directors at the 2026-05-19 meeting.

“Proposal No. 1. To elect the following nominees as Class II directors to serve until the Company’s 2029 annual meeting of stockholders or until such director’s respective successor is duly elected and qualified: Director Nominee Votes For Votes Withheld Broker Non-Votes J. Matthew Singleton 28,648,459 14,562,012 36,879,061 S. Kathryn Rouan, Ph.D. 21,960,203 21,250,268 36,879,061”

TUTOR PERINI CORP shareholders approved Approval of the Compensation of the Company’s Named Executive Officers on an Advisory (Non-binding) Basis.

“The Company’s shareholders cast their votes with respect to the approval of the compensation of the Company's named executive officers on an advisory (non-binding) basis. The final voting results on this proposal were as follows: Votes For Votes Against Abstentions Broker Non-Votes 38,631,812 952,357 283,064 5,960,026”